Estradot 75 mikrog/24 timer Norway - Norwegian - Statens legemiddelverk

estradot 75 mikrog/24 timer

sandoz a/s - Østradiolhemihydrat - depotplaster - 75 mikrog/24 timer

Estradot 100 mikrog/24 timer Norway - Norwegian - Statens legemiddelverk

estradot 100 mikrog/24 timer

sandoz a/s - Østradiolhemihydrat - depotplaster - 100 mikrog/24 timer

Ovesterin 1 mg Norway - Norwegian - Statens legemiddelverk

ovesterin 1 mg

aspen pharma trading limited - Østriol - tablett - 1 mg

Ovesterin 2 mg Norway - Norwegian - Statens legemiddelverk

ovesterin 2 mg

aspen pharma trading limited - Østriol - tablett - 2 mg

Lydisilka European Union - Norwegian - EMA (European Medicines Agency)

lydisilka

estetra sprl - estetrol monohydrate, drospirenone - contraceptives, oral - sex hormoner og modulatorer av genital systemet, - oral prevensjon. the decision to prescribe lydisilka should take into consideration the individual woman’s current risk factors, particularly those for venous thromboembolism (vte), and how the risk of vte with lydisilka compares with other combined hormonal contraceptives (chcs) (see sections 4. 3 and 4.

Rosuvastatin Glenmark 40 mg Norway - Norwegian - Statens legemiddelverk

rosuvastatin glenmark 40 mg

glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 40 mg

Rosuvastatin Glenmark 5 mg Norway - Norwegian - Statens legemiddelverk

rosuvastatin glenmark 5 mg

glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 5 mg

Rosuvastatin Glenmark 10 mg Norway - Norwegian - Statens legemiddelverk

rosuvastatin glenmark 10 mg

glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 10 mg

Rosuvastatin Glenmark 20 mg Norway - Norwegian - Statens legemiddelverk

rosuvastatin glenmark 20 mg

glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 20 mg

Ryeqo European Union - Norwegian - EMA (European Medicines Agency)

ryeqo

gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyomer - hypofysiske og hypotalamiske hormoner og analoger - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.